Stock Research for EBS

EBS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

EBS Stock Chart & Research Data

The EBS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the EBS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


EBS Due diligence Resources & Stock Charts

The EBS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View EBS Detailed Price Forecast - CNN Money CNN View EBS Detailed Summary - Google Finance
Yahoo View EBS Detailed Summary - Yahoo! Finance Zacks View EBS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View EBS Trends & Analysis - Trade-Ideas Barrons View EBS Major Holders - Barrons
NASDAQ View EBS Call Transcripts - NASDAQ Seeking View EBS Breaking News & Analysis - Seeking Alpha
Spotlight View EBS Annual Report - CompanySpotlight.com OTC Report View EBS OTC Short Report - OTCShortReport.com
TradeKing View EBS Fundamentals - TradeKing Charts View EBS SEC Filings - Bar Chart
WSJ View Historical Prices for EBS - The WSJ Morningstar View Performance/Total Return for EBS - Morningstar
MarketWatch View the Analyst Estimates for EBS - MarketWatch CNBC View the Earnings History for EBS - CNBC
StockMarketWatch View the EBS Earnings - StockMarketWatch MacroAxis View EBS Buy or Sell Recommendations - MacroAxis
Bullish View the EBS Bullish Patterns - American Bulls Short Pains View EBS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View EBS Stock Mentions - StockTwits PennyStocks View EBS Stock Mentions - PennyStockTweets
Twitter View EBS Stock Mentions - Twitter Invest Hub View EBS Investment Forum News - Investor Hub
Yahoo View EBS Stock Mentions - Yahoo! Message Board Seeking Alpha View EBS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for EBS - SECform4.com Insider Cow View Insider Transactions for EBS - Insider Cow
CNBC View EBS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for EBS - OTC Markets
Yahoo View Insider Transactions for EBS - Yahoo! Finance NASDAQ View Institutional Holdings for EBS - NASDAQ


Stock Charts

FinViz View EBS Stock Insight & Charts - FinViz.com StockCharts View EBS Investment Charts - StockCharts.com
BarChart View EBS Stock Overview & Charts - BarChart Trading View View EBS User Generated Charts - Trading View




Latest Financial News for EBS


Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Posted on Monday April 01, 2024

Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of DirectorsWARREN, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Abigail Jenkins to the Company’s Board of Direct


Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
Posted on Thursday March 28, 2024

As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN® Nasal Spray and build on its longstanding efforts with public interest entities across the country Hundreds of thousands of NARCAN® Nasal Spray cartons are available in over 32,000 retail locations in the U.S., and Emergent is working to increase reach into workplaces, businesses and other locationsApproximately 22 million doses of NARCAN®


Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
Posted on Monday March 25, 2024

GAITHERSBURG, Md., March 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has listed “No Action Indicated” or NAI status classification for the company's Baltimore Bayview manufacturing facility. Based on this outcome, the Baltimore Bayview facility is considered to be in an acceptable state of compliance with regard to current good manufacturing practices (cGMP). “Quality and compliance excellence remains a top priori


Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
Posted on Thursday March 07, 2024

Net Loss Narrows in Q4; Full Year Revenues Hit Guidance Mid-Point


Stock Market & Investing Books

Enter a stock symbol to view the stock details.